HLUN-A:CPH
H Lundbeck A/S Class A
DKKÂ 44.05
arrow_upward
+0.92%(+0.40) 1D
Sep 28, 2:56:10 PM GMT+2 · DKK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLUN-A...
Open
DKKÂ 43.65
High
DKKÂ 44.25
Low
DKKÂ 43.20
Mkt. cap
44.75B
Avg. vol.
199.81K
Volume
61.88K
52-wk high
DKKÂ 45.00
52-wk low
DKKÂ 31.40
Shares outstanding
199.15M
No. of employees
5K
Open
DKKÂ 43.65
High
DKKÂ 44.25
Low
DKKÂ 43.20
Mkt. cap
44.75B
Avg. vol.
199.81K
Volume
61.88K
52-wk high
DKKÂ 45.00
52-wk low
DKKÂ 31.40
Shares outstanding
199.15M
No. of employees
5K
News stories
From web sources and news partners
The Business Journals
·
2 days ago
Danish drugmaker Lundbeck relocates U.S. headquarters to Boston's Seaport
Fierce Pharma
·
2 days ago
Lundbeck to move US digs to Boston as it eyes bigger innovation frontiers
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class A
CEOCharl Van Zyl
Employees5K
FoundedAug 14, 1915
Headquarters-
SectorPharmaceutical industry
Websitelundbeck.com